Skin and joint infection by Mycobacterium chelonae:: Rescue treatment with interferon gamma

被引:4
作者
Jousse-Joulin, Sandrine
Garre, Michel
Guennoc, Xavier
Destombe, Claire
Samjee, Isabelle
Devauchelle-Pensec, Valerie
Saraux, Alain
机构
[1] Brest Teaching Hosp, Dept Rheumatol, Brest, France
[2] Brest Teaching Hosp, Internal Med & Infect Dis Dept, Brest, France
关键词
Mycobacterium chelonae; ankylosing spondylitis; septic arthritis; interferon gamma; IN-VITRO ACTIVITY; CLARITHROMYCIN; RESISTANCE; FORTUITUM; SUBGROUPS; ABSCESSUS; THERAPY;
D O I
10.1016/j.jbspin.2006.11.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Atypical mycobacteria are environmental organisms that cause opportunistic infections in humans. Case report: A 50-year-old electronics engineer sought advice about starting TNF alpha antagonist therapy for ankylosing spondylitis. Disease duration was 23 years and current treatment was methylprednisolone 4 mg/d. Atypical skin lesions and knee arthritis were noted. Fluid aspirated from the knee showed inflammatory properties and a few acid-fast bacteria, which a line probe assay identified as Mycobacterium chelonae. The same organism was found in a skin biopsy from a thigh lesion. Antimicrobial treatment was started immediately. Inadequate results 6 months later prompted synovectomy of the knee followed by interferon gamma, 50 mu g/m(2) body surface area subcutaneously 3 times a week. After 16 months. there were no new skin or joint lesions, and the antimicrobials and interferon gamma were therefore discontinued. Conclusion: This highly unusual case suggests that interferon gamma may be effective in patients with M. chelonae infection that fails to respond adequately to antimicrobials. (c) 2007 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:385 / 388
页数:4
相关论文
共 15 条
[1]   ACTIVITIES OF 4 MACROLIDES, INCLUDING CLARITHROMYCIN, AGAINST MYCOBACTERIUM-FORTUITUM, MYCOBACTERIUM-CHELONAE, AND M-CHELONAE-LIKE ORGANISMS [J].
BROWN, BA ;
WALLACE, RJ ;
ONYI, GO ;
DEROSAS, V ;
WALLACE, RJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (01) :180-184
[2]   Successful treatment of disseminated Mycobacterium chelonae infection with linezolid [J].
Brown-Elliot, BA ;
Wallace, RJ ;
Blinkhorn, R ;
Crist, CJ ;
Mann, LB .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (08) :1433-1434
[3]   Treatment of refractory disseminated Mycobacterium abscessus infection with interferon gamma therapy [J].
Colsky, AS ;
Hanly, A ;
Elgart, G ;
Kerdel, FA .
ARCHIVES OF DERMATOLOGY, 1999, 135 (02) :125-127
[4]   In vitro activity of new fluoroquinolones and linezolid against nontuberculous mycobacteria [J].
Díaz, JCR ;
López, M ;
Ruiz, M ;
Royo, G .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2003, 21 (06) :585-588
[5]   Development of resistance to clarithromycin after treatment of cutaneous Mycobacterium chelonae infection [J].
Driscoll, MS ;
Tyring, SK .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1997, 36 (03) :495-496
[6]  
LEVYFREBAULT VV, 1991, MED MALADIES INFECT, V21, P16
[7]   Mycobacterium chelonae tenosynovitis of the hand [J].
Mateo, L ;
Rufi, G ;
Nolla, JM ;
Alcaide, F .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2004, 34 (03) :617-622
[8]   Skin and wound infection by rapidly growing mycobacteria -: An unexpected complication of liposuction and liposculpture [J].
Murillo, J ;
Torres, M ;
Bofill, L ;
Ríos-Fabra, A ;
Irausquin, E ;
Istúriz, R ;
Guzmán, M ;
Castro, J ;
Rubino, L ;
Cordido, M .
ARCHIVES OF DERMATOLOGY, 2000, 136 (11) :1347-1352
[9]  
SWENSON JM, 1985, ANTIMICROB AGENTS CH, V28, P807, DOI 10.1128/AAC.28.6.807
[10]   RAPID DEVELOPMENT OF RESISTANCE TO CLARITHROMYCIN FOLLOWING MONOTHERAPY FOR DISSEMINATED MYCOBACTERIUM-CHELONAE INFECTION IN A HEART-TRANSPLANT PATIENT [J].
TEBAS, P ;
SULTAN, F ;
WALLACE, RJ ;
FRASER, V .
CLINICAL INFECTIOUS DISEASES, 1995, 20 (02) :443-444